The pound faded to USD1.2286 early Thursday, from USD1.2351. Sterling fell as low as USD1.2239 on Thursday, its worst level since November 2023. The euro was largely unmoved at USD1.0301 from ...
Unite expects 97% to 98% occupancy and 4% to 5% rental growth for the 2025/26 academic year, compared to 97.5% occupancy and like-for-like rental growth of 8.2% in academic year 2024/25, and compared ...
RBG Holdings has alleged Rosenblatt bought another law firm monitored by the Solicitors Regulation Authority, before making various demands to RBG. The chronology renders negotiations between the ...
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Nichols will join Coats as CFO on April 24 and assume full responsibilities after its annual general meeting on May 21, succeeding Jackie Callaway, who has mutually agreed with the board of Coats to ...
(Alliance News) - Global Petroleum Ltd saw its shares drop 24% on Tuesday afternoon as it reported a successful capital raise to advance its Juno project.
The FTSE 100 index ended down 4.38 points, 0.1%, at 8,245.28. The FTSE 250 tumbled 262.28 points, 1.3%, at 20,350.37. The AIM All-Share fell 3.67 points, 0.5%, at 725.28.
Redburn raises Barratt Redrow to 'buy' (neutral) - price target 540 (530) pence Redburn raises Persimmon to 'buy' (neutral) - price target 1,510 (1,610) pence RBC cuts Unilever to 'underperform' ...
Through its Croatian subsidiary, IGeoPen doo, A14 Energy owns three geothermal waters exploration licences in the Pannonian Basin in Croatia.
In contrast to the gloomy mood in Europe, US markets pushed higher. At the time of the London close, the Dow Jones Industrial Average was up 0.6%, the S&P 500 was 1.0% higher and the Nasdaq Composite ...
(Alliance News) - Shares in Diageo PLC fell on Friday after the US Surgeon General called for alcoholic beverage labels to include cancer warnings. Shares in the owner of Guinness and Johnnie Walker ...
(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.